GeoVax Labs, Inc. announced that David A. Dodd has been appointed President and Chief Executive Officer, effective September 1, succeeding Robert McNally, PhD, who has announced his retirement. Dr. McNally will remain as a member of the company's Board of Directors. Mr. Dodd joined the GeoVax Board of Directors in March 2010 and was elected Chairman in January 2011.

His executive management experience in the pharmaceutical and biotechnology industries spans more than 40 years. From September 2017 to June 2018, Mr. Dodd served as CEO, and as a member of the Board of Directors, of Medizone International, Inc.